Medication info
Rosuvael Tablets 10 mg (Rosuvastatin Calcium)

Rosuvael Tablets 10 mg (Rosuvastatin Calcium)

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›10.4mg / 1 tablet
Manufacturer / importer
McNulty Pharmaceuticals Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
30 tablets/box [(15 tablets / Alu Alu × 2)]
Approval status
Active

MFDS item code 202002664 · Approved 2020.04.16 · Insurance code 641502740

Summary

Main use
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and reduction of cardiovascular disease risk
Who uses it
Adults · Children
Adult dosage
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), combined hyperlipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients receiving this drug must follow a standard cholesterol-lowering diet before and during treatment. This drug may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. The dose may be adjusted to the maintenance dose if a greater reduction in LDL cholesterol is required. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. 3. Older adults: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering 20 milligrams of this drug to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer this drug to patients with active liver disease. 6. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Children's dosage
Ages 10 years ∼ 17 years: The usual dose range is 5 milligrams ∼ 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) Adjust the dose individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.

Ingredients

Manufacturer
McNulty Pharmaceuticals Co., Ltd.

Efficacy & effects

Improvement of dyslipidemia, inhibition of atherosclerosis progression, and reduction of cardiovascular disease risk

  • Hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerosis
  • dysbetalipoproteinemia
  • increased high-sensitivity C-reactive protein
  • hypertension
  • low HDL cholesterol
  • smoking
  • family history of early coronary heart disease
  • risk of stroke
View approved original text

This medication is used as an adjunct therapy when dietary and exercise management is insufficient for patients with primary hypercholesterolemia and mixed dyslipidemia. It also helps lower blood cholesterol levels in patients with homozygous familial hypercholesterolemia and dysbetalipoproteinemia. It lowers LDL cholesterol in hypercholesterolemia patients, delaying the progression of atherosclerosis, and is effective in children aged 10 years and older with familial hypercholesterolemia. This medication reduces the risk of stroke, myocardial infarction, and revascularization procedures in adult patients at high risk for cardiovascular disease. Overall, it is an effective medication for improving cardiovascular health and managing blood lipid levels.

Dosage and Administration

Adult dosage

1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), combined hyperlipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients receiving this drug must follow a standard cholesterol-lowering diet before and during treatment. This drug may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. The dose may be adjusted to the maintenance dose if a greater reduction in LDL cholesterol is required. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. 3. Older adults: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering 20 milligrams of this drug to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer this drug to patients with active liver disease. 6. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.

Children's dosage

Ages 10 years ∼ 17 years: The usual dose range is 5 milligrams ∼ 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) Adjust the dose individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.

Precautions

This medication should not be used in patients with certain allergic reactions and is not recommended for patients with severely impaired liver function or muscle disorders. Women who are pregnant or breastfeeding should avoid taking this medication as it may pose risks to the fetus or infant, and women of childbearing age should use appropriate contraception to prevent pregnancy. This medication may cause muscle-related side effects, such as myalgia or muscle weakness; therefore, if unusual symptoms occur in the muscles, immediate consultation with healthcare personnel is necessary. Liver function abnormalities can occur, so liver function tests should be conducted regularly before and during treatment. Patients who consume alcohol excessively or have a history of liver disease should use this medication with caution, and those with hypothyroidism or renal impairment should also be careful. Interactions may occur when taken with other medications; therefore, all medications being taken should be reported to healthcare personnel, and careful monitoring is required for concomitant use. Particularly, the blood concentration of this medication may increase when taken with certain drugs, raising the risk of muscle damage; hence, use with such drugs should be avoided or dosage adjustments may be needed. During the use of this medication, if symptoms such as sudden myalgia, muscle weakness, fever, or fatigue occur, immediate consultation with a physician is essential, and if symptoms are severe, discontinuation of medication may be necessary. In children and adolescents, usage may affect growth and secondary sexual characteristics, requiring close monitoring by healthcare personnel. In case of overdose, there is no specific antidote, so immediate medical attention and proper treatment and examination are required. This medication contains lactose, so patients with lactose intolerance should avoid it. Caution is needed while driving or operating machinery as dizziness may occur. Severe skin reactions may occur; if symptoms such as skin rash, swelling, or difficulty breathing arise, immediate cessation of the medication and consultation with healthcare personnel is necessary.

Side effects

Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ophthalmoplegia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), drug-induced erythroderma, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal hepatic failure, cognitive impairment, increased ALT, chest pain, increased CK, increased AST, joint pain, fatigue, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, abnormal liver function tests, syncope, systemic pain, muscle cramps, gout, erectile dysfunction, acute kidney failure, oliguria, increased serum creatinine

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The recommended storage temperature is between 1 to 30 degrees Celsius at room temperature to maintain the drug's efficacy and safety for a longer duration.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

30 tablets/box [(15 tablets / Alu Alu × 2)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.